Following is my interpretation of recent market size developments:
There has been a vast expansion in Eligible FTSD (full thickness skin defects) that has been revealed by the Form 8-K released to the market on 27th June 2023.
Prior to the June approvals, Avita was guiding for a 5-6x increase in their market size for eligible FTSD procedures following approval for soft tissue. That is from just their burns market to include burns and soft tissue defects after approval for soft tissue.
Well, the Form 8-K now reveals a market size of approximately 391,000 eligible FTSD procedures due to the "FDA Approved Expanded Indication of FTSD". That is now 15-16x larger than the previous 25K burns market prior to the June approval for soft tissue.
For those more experienced in matters relating to AVH, please tell me if I have misinterpreted this.
The near term future, page-56
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.70 |
Change
0.060(2.27%) |
Mkt cap ! $187.7M | |||
| Open | High | Low | Value | Volume |
| $2.71 | $2.73 | $2.67 | $185.4K | 68.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2297 | $2.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.70 | 657 | 3 |
View Market Depth
| Last trade - 13.50pm 02/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |